Natural Health Trends Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Accumulated Other Comprehensive (Loss) Income	Treasury Stock
Preferred stock, beginning balance (in shares) at Dec. 31, 2017		0
Common stock, beginning balance (in shares) at Dec. 31, 2017			12,979,414
Treasury stock, beginning balance (in shares) at Dec. 31, 2017							(1,637,524)
Stockholders' equity, beginning balance at Dec. 31, 2017	$ 90,621	$ 0	$ 13	$ 86,683	$ 44,908	$ (413)	$ (40,570)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	8,824				8,824
Common stock issued	554			(268)			$ 822
Common stock issued (in shares)							34,202
Dividends declared	(1,479)				(1,479)
Foreign currency translation adjustment	397					397
Unrealized gains (losses) on available-for-sale securities	(11)					(11)
Preferred stock, ending balance (in shares) at Mar. 31, 2018		0
Common stock, ending balance (in shares) at Mar. 31, 2018			12,979,414
Treasury stock, beginning balance (in shares) at Mar. 31, 2018							(1,603,322)
Stockholders' equity, ending balance at Mar. 31, 2018	98,906	$ 0	$ 13	86,415	52,253	(27)	$ (39,748)
Preferred stock, beginning balance (in shares) at Dec. 31, 2017		0
Common stock, beginning balance (in shares) at Dec. 31, 2017			12,979,414
Treasury stock, beginning balance (in shares) at Dec. 31, 2017							(1,637,524)
Stockholders' equity, beginning balance at Dec. 31, 2017	90,621	$ 0	$ 13	86,683	44,908	(413)	$ (40,570)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	17,847
Foreign currency translation adjustment	(365)
Unrealized gains (losses) on available-for-sale securities	4
Preferred stock, ending balance (in shares) at Jun. 30, 2018		0
Common stock, ending balance (in shares) at Jun. 30, 2018			12,979,414
Treasury stock, beginning balance (in shares) at Jun. 30, 2018							(1,603,322)
Stockholders' equity, ending balance at Jun. 30, 2018	85,568	$ 0	$ 13	86,415	39,662	(774)	$ (39,748)
Preferred stock, beginning balance (in shares) at Mar. 31, 2018		0
Common stock, beginning balance (in shares) at Mar. 31, 2018			12,979,414
Treasury stock, beginning balance (in shares) at Mar. 31, 2018							(1,603,322)
Stockholders' equity, beginning balance at Mar. 31, 2018	98,906	$ 0	$ 13	86,415	52,253	(27)	$ (39,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	9,023				9,023
Dividends declared	(21,614)				(21,614)
Foreign currency translation adjustment	(762)					(762)
Unrealized gains (losses) on available-for-sale securities	15					15
Preferred stock, ending balance (in shares) at Jun. 30, 2018		0
Common stock, ending balance (in shares) at Jun. 30, 2018			12,979,414
Treasury stock, beginning balance (in shares) at Jun. 30, 2018							(1,603,322)
Stockholders' equity, ending balance at Jun. 30, 2018	$ 85,568	$ 0	$ 13	86,415	39,662	(774)	$ (39,748)
Preferred stock, beginning balance (in shares) at Dec. 31, 2018	0	0
Common stock, beginning balance (in shares) at Dec. 31, 2018	12,979,414		12,979,414
Treasury stock, beginning balance (in shares) at Dec. 31, 2018	(1,603,322)						(1,603,322)
Stockholders' equity, beginning balance at Dec. 31, 2018	$ 89,861	$ 0	$ 13	86,415	44,431	(1,250)	$ (39,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,923)				(1,923)
Common stock issued	377			(166)			$ 543
Common stock issued (in shares)							22,603
Dividends declared	(2,736)				(2,736)
Foreign currency translation adjustment	259					259
Unrealized gains (losses) on available-for-sale securities	17					17
Preferred stock, ending balance (in shares) at Mar. 31, 2019		0
Common stock, ending balance (in shares) at Mar. 31, 2019			12,979,414
Treasury stock, beginning balance (in shares) at Mar. 31, 2019							(1,580,719)
Stockholders' equity, ending balance at Mar. 31, 2019	$ 85,855	$ 0	$ 13	86,249	39,772	(974)	$ (39,205)
Preferred stock, beginning balance (in shares) at Dec. 31, 2018	0	0
Common stock, beginning balance (in shares) at Dec. 31, 2018	12,979,414		12,979,414
Treasury stock, beginning balance (in shares) at Dec. 31, 2018	(1,603,322)						(1,603,322)
Stockholders' equity, beginning balance at Dec. 31, 2018	$ 89,861	$ 0	$ 13	86,415	44,431	(1,250)	$ (39,748)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,526)
Foreign currency translation adjustment	47
Unrealized gains (losses) on available-for-sale securities	$ 11
Preferred stock, ending balance (in shares) at Jun. 30, 2019	0	0
Common stock, ending balance (in shares) at Jun. 30, 2019	12,979,414		12,979,414
Treasury stock, beginning balance (in shares) at Jun. 30, 2019	(2,193,448)						(2,193,448)
Stockholders' equity, ending balance at Jun. 30, 2019	$ 79,352	$ 0	$ 13	86,249	40,169	(1,192)	$ (45,887)
Preferred stock, beginning balance (in shares) at Mar. 31, 2019		0
Common stock, beginning balance (in shares) at Mar. 31, 2019			12,979,414
Treasury stock, beginning balance (in shares) at Mar. 31, 2019							(1,580,719)
Stockholders' equity, beginning balance at Mar. 31, 2019	85,855	$ 0	$ 13	86,249	39,772	(974)	$ (39,205)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	397				397
Repurchase of common stock (in shares)							(612,729)
Repurchase of common stock	(6,682)						$ (6,682)
Foreign currency translation adjustment	(212)					(212)
Unrealized gains (losses) on available-for-sale securities	$ (6)					(6)
Preferred stock, ending balance (in shares) at Jun. 30, 2019	0	0
Common stock, ending balance (in shares) at Jun. 30, 2019	12,979,414		12,979,414
Treasury stock, beginning balance (in shares) at Jun. 30, 2019	(2,193,448)						(2,193,448)
Stockholders' equity, ending balance at Jun. 30, 2019	$ 79,352	$ 0	$ 13	$ 86,249	$ 40,169	$ (1,192)	$ (45,887)